EMVision Medical Devices (EMV) Stock Overview
Engages in the research, development, and commercialization of neurodiagnostic technology for stroke diagnosis and monitoring, and other medical imaging needs in Australia. More details
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 1/6 |
| Past Performance | 0/6 |
| Financial Health | 4/6 |
| Dividends | 0/6 |
Rewards
Risk Analysis
EMV Community Fair Values
Create NarrativeSee what others think this stock is worth. Follow their fair value or set your own to get alerts.
EMVision Medical Devices Ltd Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | AU$2.00 |
| 52 Week High | AU$2.22 |
| 52 Week Low | AU$1.63 |
| Beta | 0.81 |
| 1 Month Change | 14.94% |
| 3 Month Change | 17.65% |
| 1 Year Change | -7.41% |
| 3 Year Change | 33.78% |
| 5 Year Change | -6.98% |
| Change since IPO | 555.74% |
Recent News & Updates
Recent updates
EMVision Medical Devices (ASX:EMV) Is Using Debt Safely
Aug 28
Is EMVision Medical Devices (ASX:EMV) A Risky Investment?
Nov 21Here's Why We're Not At All Concerned With EMVision Medical Devices' (ASX:EMV) Cash Burn Situation
Apr 24EMVision Medical Devices Ltd's (ASX:EMV) CEO Compensation Is Looking A Bit Stretched At The Moment
Nov 09We're Not Very Worried About EMVision Medical Devices' (ASX:EMV) Cash Burn Rate
Oct 04Companies Like EMvision Medical Devices (ASX:EMV) Are In A Position To Invest In Growth
Jun 17We're Not Very Worried About EMvision Medical Devices' (ASX:EMV) Cash Burn Rate
Jan 07We're Not Very Worried About EMvision Medical Devices' (ASX:EMV) Cash Burn Rate
Oct 04We're Not Very Worried About EMvision Medical Devices' (ASX:EMV) Cash Burn Rate
Jun 08Here's Why We're Not Too Worried About EMvision Medical Devices' (ASX:EMV) Cash Burn Situation
Feb 22Investors Who Bought EMvision Medical Devices (ASX:EMV) Shares A Year Ago Are Now Up 319%
Dec 20
We Think EMvision Medical Devices (ASX:EMV) Can Afford To Drive Business Growth
Nov 24Shareholder Returns
| EMV | AU Medical Equipment | AU Market | |
|---|---|---|---|
| 7D | 8.7% | 2.3% | 0.1% |
| 1Y | -7.4% | 1.2% | 10.7% |
Return vs Industry: EMV underperformed the Australian Medical Equipment industry which returned 1.2% over the past year.
Return vs Market: EMV underperformed the Australian Market which returned 10.7% over the past year.
Price Volatility
| EMV volatility | |
|---|---|
| EMV Average Weekly Movement | 4.7% |
| Medical Equipment Industry Average Movement | 10.0% |
| Market Average Movement | 8.9% |
| 10% most volatile stocks in AU Market | 19.6% |
| 10% least volatile stocks in AU Market | 3.5% |
Stable Share Price: EMV has not had significant price volatility in the past 3 months compared to the Australian market.
Volatility Over Time: EMV's weekly volatility (5%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2017 | n/a | Scott Kirkland | www.emvision.com.au |
EMVision Medical Devices Ltd engages in the research, development, and commercialization of neurodiagnostic technology for stroke diagnosis and monitoring, and other medical imaging needs in Australia. It offers non-invasive brain scanners including bedside device emu, an ultra-light weight first responder pre-hospital device. EMVision Medical Devices Ltd was incorporated in 2017 and is based in Macquarie Park, Australia.
EMVision Medical Devices Ltd Fundamentals Summary
| EMV fundamental statistics | |
|---|---|
| Market cap | AU$171.03m |
| Earnings (TTM) | -AU$9.81m |
| Revenue (TTM) | AU$5.05m |
Is EMV overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| EMV income statement (TTM) | |
|---|---|
| Revenue | AU$5.05m |
| Cost of Revenue | AU$0 |
| Gross Profit | AU$5.05m |
| Other Expenses | AU$14.86m |
| Earnings | -AU$9.81m |
Last Reported Earnings
Jun 30, 2025
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.11 |
| Gross Margin | 100.00% |
| Net Profit Margin | -194.10% |
| Debt/Equity Ratio | 28.6% |
How did EMV perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/08/30 21:11 |
| End of Day Share Price | 2025/08/29 00:00 |
| Earnings | 2025/06/30 |
| Annual Earnings | 2025/06/30 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
EMVision Medical Devices Ltd is covered by 1 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Martyn Jacobs | Bell Potter |